Eli Lilly & Co

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Eli Lilly & Co
CIK #0000059478
EDGAR Form CIK 2011 - 2026
10-K [0000059478]
10-Q [0000059478]
3 [0000059478]
4 [0000059478]
5 [0000059478]
8-K [0000059478]
SC 13D [0000059478]
SC 13G [0000059478]
Form 13D/13G Filer Form 13D/13G Subject Filed
Vanguard Capital Management LLC Eli Lilly & Co [2026-05-01]
Eli Lilly & Co Aktis Oncology Inc [2026-01-15]
Eli Lilly & Co Sigilon Therapeutics Inc [2023-07-07]
Eli Lilly & Co Akouos Inc [2022-10-27]
Eli Lilly & Co Immunocore Holdings PLC [2022-02-10]
Eli Lilly & Co Foghorn Therapeutics Inc [2021-12-13]
Eli Lilly & Co Proqr Therapeutics NV [2021-09-10]
Eli Lilly & Co AC Immune Sa [2021-02-12]
Eli Lilly & Co Sigilon Therapeutics Inc [2021-02-12]
Eli Lilly & Co Avidity Biosciences Inc [2021-02-12]
View All
Form 3/4/5 Subject 2011 - 2026
Eli Lilly & Co
Fyrwald J Erik
Alvarez Ralph
Sulzberger Gabrielle
Luciano Juan R
Yuffa Ilya
Lilly Endowment Inc
Dozier Eric
Zakrowski Donald A
Custer Kenneth L
Brown Adrienne S
Montarce Lucas
Skovronsky Daniel
Hakim Anat
van Naarden Jacob
Rau Diogo
Ricks David A
Hernandez Edgardo
Jonsson Patrik
Aktis Oncology Inc
Ho Carole
Hedley Mary Lynne
Bertozzi Carolyn R
Jackson Jamere
Moeller Jon R
Baicker Katherine
Johnson Kimberly H
Kaelin William G Jr
Seymour Melissa
White Anne E
Walker Karen
Brooks Gordon J
Norton Johna
Ashkenazi Anat
Weems Alonzo
Runge Marschall S
Sigilon Therapeutics Inc
Shenandoah Acquisition Corp
Tai Jackson P
Pusey Leigh Ann
Mason Michael B
Akouos Inc
Kearny Acquisition Corp
Fry Stephen F
Eskew Michael L
Barnes Melissa S
O'Neill Myles
Shah Aarti S
Smiley Joshua L
Zulueta Alfonso G
Prevail Therapeutics Inc
Tyto Acquisition Corp
Seifert Kathi P
Avidity Biosciences Inc
Bald Eagle Acquisition Corp
Dermira Inc
Harrington Michael J
Shaw Christi
Marram Ellen R
Elanco Animal Health Inc
Conterno Enrique A
Zymeworks BC Inc
Simmons Jeffrey N
Cypherpunk Technologies Inc
Mahony Susan
Lundberg Jan M
Crowe Maria A
Rice Derica W
Lechleiter John C
Hoover R David
Prendergast Franklyn G
CoLucid Pharmaceuticals Inc
ProCar Acquisition Corp
Walsh Fionnuala M
Peterson Barton R
Spyre Therapeutics Inc
Horn Karen N
Zosano Pharma Corp
Oberhelman Douglas R
Coherus Oncology Inc
Lilly Ventures Fund I LLC
Dare Bioscience Inc
Tapiero Jacques
Bischoff Winfried F W Sir
Gilman Alfred G
Armitage Robert A
Nobles Anne
Hanish Arnold C
Carmine Bryce D
Deane Frank M
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Eli Lilly & Co LLY
Common Stock
2026-03-16 Grant 5.01 $989.12 4,955
Eli Lilly & Co LLY
Common Stock
2026-03-16 Grant 12.55 $989.12 12,413
Eli Lilly & Co LLY
Common Stock
2026-03-16 Grant 10.03 $989.12 9,921
Eli Lilly & Co LLY
Common Stock
2026-03-16 Grant 16.09 $989.12 15,915
Eli Lilly & Co LLY
Common Stock
2026-02-19 Gift 481 $0.00
Eli Lilly & Co LLY
Common Stock
2026-02-17 Grant 11.99 $1,036.05 12,422
Eli Lilly & Co LLY
Common Stock
2026-02-17 Grant 15.36 $1,036.05 15,914
Eli Lilly & Co LLY
Common Stock
2026-02-17 Grant 9.57 $1,036.05 9,915
Eli Lilly & Co LLY
Common Stock
2026-02-17 Grant 4.79 $1,036.05 4,963
Eli Lilly & Co LLY
Common Stock
2026-02-16 Option exercise 391 $0.00
Eli Lilly & Co LLY
Restricted Stock Unit · derivative
2026-02-16 Option exercise 207 $0.00
Eli Lilly & Co LLY
Common Stock
2026-02-16 Tax withheld 169.97 $1,040.00 176,769
Eli Lilly & Co LLY
Common Stock
2026-02-16 Tax withheld 159.73 $1,040.00 166,119
Eli Lilly & Co LLY
Common Stock
2026-02-16 Option exercise 368 $0.00
Eli Lilly & Co LLY
Restricted Stock Unit · derivative
2026-02-16 Option exercise 368 $0.00
Eli Lilly & Co LLY
Common Stock
2026-02-16 Tax withheld 81.55 $1,040.00 84,812
Eli Lilly & Co LLY
Common Stock
2026-02-16 Option exercise 184 $0.00
Eli Lilly & Co LLY
Restricted Stock Unit · derivative
2026-02-16 Option exercise 184 $0.00
Eli Lilly & Co LLY
Restricted Stock Unit · derivative
2026-02-16 Option exercise 391 $0.00
Eli Lilly & Co LLY
Common Stock
2026-02-16 Option exercise 207 $0.00
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com